{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:41:03Z","timestamp":1794944463490,"version":"4.9.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["92159304, 82372022, 82227806, and 82171958"],"award-info":[{"award-number":["92159304, 82372022, 82227806, and 82171958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["92159304, 82372022, 82227806, and 82171958"],"award-info":[{"award-number":["92159304, 82372022, 82227806, and 82171958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["92159304, 82372022, 82227806, and 82171958"],"award-info":[{"award-number":["92159304, 82372022, 82227806, and 82171958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["92159304, 82372022, 82227806, and 82171958"],"award-info":[{"award-number":["92159304, 82372022, 82227806, and 82171958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["no. 2023YFF0714200"],"award-info":[{"award-number":["no. 2023YFF0714200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["no. 2023YFF0714200"],"award-info":[{"award-number":["no. 2023YFF0714200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["no. 2023YFF0714200"],"award-info":[{"award-number":["no. 2023YFF0714200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["no. 2023YFF0714200"],"award-info":[{"award-number":["no. 2023YFF0714200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Basic and Applied Basic Research Fund","award":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"],"award-info":[{"award-number":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"]}]},{"name":"Guangdong Basic and Applied Basic Research Fund","award":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"],"award-info":[{"award-number":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"]}]},{"name":"Guangdong Basic and Applied Basic Research Fund","award":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"],"award-info":[{"award-number":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"]}]},{"name":"Guangdong Basic and Applied Basic Research Fund","award":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"],"award-info":[{"award-number":["2024A1515030212, 2023A1515010747, 2023A1515140133, and 2022A1515140102"]}]},{"name":"Shenzhen Medical Research Funds","award":["B2302021 and E3A1051001"],"award-info":[{"award-number":["B2302021 and E3A1051001"]}]},{"name":"Shenzhen Medical Research Funds","award":["B2302021 and E3A1051001"],"award-info":[{"award-number":["B2302021 and E3A1051001"]}]},{"name":"Shenzhen Medical Research Funds","award":["B2302021 and E3A1051001"],"award-info":[{"award-number":["B2302021 and E3A1051001"]}]},{"name":"Shenzhen Medical Research Funds","award":["B2302021 and E3A1051001"],"award-info":[{"award-number":["B2302021 and E3A1051001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The blood-brain barrier (BBB) poses a major challenge to the effective delivery of therapeutic agents for the treatment of central nervous system (CNS) disorders. The integration of cell membrane engineering with nanotechnology has recently enabled the development of membrane-engineered nanoparticles (CNPs). These nanocarriers exhibit enhanced BBB penetration and improved CNS targeting. This review systematically summarizes the latest advances in the development and application of CNPs, emphasizing how different cellular sources\u2014such as erythrocytes, platelets, tumor cells, and leukocytes\u2014impact delivery efficiency and therapeutic outcomes. We also examine the molecular mechanisms underlying nanoparticle-BBB interactions and highlight the importance of biosafety evaluations. Moreover, critical barriers to clinical translation, including large-scale manufacturing challenges, batch-to-batch variability, and regulatory complexities, are discussed. Finally, we explore emerging strategies\u2014particularly the integration of artificial intelligence (AI)\u2014that hold potential for overcoming existing clinical gaps, enabling the rational design and optimized development of CNP-based therapeutics for CNS disorders. By integrating mechanistic insights with translational perspectives, this review provides a clear conceptual and technological foundation for the development of next-generation CNS-targeted nanotherapeutics.<\/jats:p>","DOI":"10.1186\/s12951-025-03572-y","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T22:39:07Z","timestamp":1751927947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Recent advances of engineering cell membranes for nanomedicine delivery across the blood\u2013brain barrier"],"prefix":"10.1186","volume":"23","author":[{"given":"Shengnan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Butch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghai","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"3572_CR1","doi-asserted-by":"publisher","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","volume":"224","author":"J Xie","year":"2019","unstructured":"Xie J, Shen Z, Anraku Y, Kataoka K, Chen X. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials. 2019;224:119491.","journal-title":"Biomaterials"},{"key":"3572_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood\u2013brain barrier: structure, regulation and drug delivery. Signal Transduct Target Ther. 2023;8:217.","journal-title":"Signal Transduct Target Ther"},{"key":"3572_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the Blood-Brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914.","journal-title":"Front Physiol"},{"key":"3572_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3171\/2019.10.JNS192206","volume":"134","author":"SH Park","year":"2021","unstructured":"Park SH, Kim MJ, Jung HH, Chang WS, Choi HS, Rachmilevitch I, et al. Safety and feasibility of multiple blood-brain barrier disruptions for the treatment of glioblastoma in patients undergoing standard adjuvant chemotherapy. J Neurosurg. 2021;134:475\u201383.","journal-title":"J Neurosurg"},{"key":"3572_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.addr.2014.01.008","volume":"72","author":"M Aryal","year":"2014","unstructured":"Aryal M, Arvanitis CD, Alexander PM, McDannold N. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev. 2014;72:94\u2013109.","journal-title":"Adv Drug Deliv Rev"},{"key":"3572_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/pharmaceutics14040833","volume":"14","author":"K Gandhi","year":"2022","unstructured":"Gandhi K, Barzegar-Fallah A, Banstola A, Rizwan SB, Reynolds JNJ. Ultrasound-Mediated Blood-Brain barrier disruption for drug delivery: A systematic review of protocols, efficacy, and safety outcomes from preclinical and clinical studies. Pharmaceutics. 2022;14:833.","journal-title":"Pharmaceutics"},{"key":"3572_CR7","doi-asserted-by":"publisher","first-page":"37746","DOI":"10.1021\/acsami.1c12675","volume":"13","author":"Y Liu","year":"2021","unstructured":"Liu Y, Hong H, Xue J, Luo J, Liu Q, Chen X, et al. Near-Infrared Radiation-Assisted drug delivery nanoplatform to realize Blood-Brain barrier crossing and protection for parkinsonian therapy. ACS Appl Mater Interfaces. 2021;13:37746\u201360.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3572_CR8","doi-asserted-by":"publisher","first-page":"120339","DOI":"10.1016\/j.biomaterials.2020.120339","volume":"260","author":"S Xiong","year":"2020","unstructured":"Xiong S, Li Z, Liu Y, Wang Q, Luo J, Chen X, et al. Brain-targeted delivery shuttled by black phosphorus nanostructure to treat parkinson\u2019s disease. Biomaterials. 2020;260:120339.","journal-title":"Biomaterials"},{"key":"3572_CR9","doi-asserted-by":"publisher","first-page":"119822","DOI":"10.1016\/j.biomaterials.2020.119822","volume":"237","author":"H Zhou","year":"2020","unstructured":"Zhou H, Gong Y, Liu Y, Huang A, Zhu X, Liu J, et al. Intelligently thermoresponsive flower-like Hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of Tau and neuronal damage for the treatment of alzheimer\u2019s disease. Biomaterials. 2020;237:119822.","journal-title":"Biomaterials"},{"key":"3572_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release Off J Control Release Soc. 2012;160:117\u201334.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"3572_CR11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.7150\/thno.11852","volume":"5","author":"S Tan","year":"2015","unstructured":"Tan S, Wu T, Zhang D, Zhang Z. Cell or cell Membrane-Based drug delivery systems. Theranostics. 2015;5:863\u201381.","journal-title":"Theranostics"},{"key":"3572_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","volume":"200","author":"A Wicki","year":"2015","unstructured":"Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release Off J Control Release Soc. 2015;200:138\u201357.","journal-title":"J Control Release Off J Control Release Soc"},{"key":"3572_CR13","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.brainresbull.2018.08.003","volume":"142","author":"B Nabi","year":"2018","unstructured":"Nabi B, Rehman S, Khan S, Baboota S, Ali J. Ligand conjugation: an emerging platform for enhanced brain drug delivery. Brain Res Bull. 2018;142:384\u201393.","journal-title":"Brain Res Bull"},{"key":"3572_CR14","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.7150\/thno.41322","volume":"10","author":"S Kang","year":"2020","unstructured":"Kang S, Duan W, Zhang S, Chen D, Feng J, Qi N. Muscone\/RI7217 co-modified upward messenger DTX liposomes enhanced permeability of blood-brain barrier and targeting glioma. Theranostics. 2020;10:4308\u201322.","journal-title":"Theranostics"},{"key":"3572_CR15","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","volume":"6","author":"L Sercombe","year":"2015","unstructured":"Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286.","journal-title":"Front Pharmacol"},{"key":"3572_CR16","doi-asserted-by":"publisher","first-page":"2006484","DOI":"10.1002\/smll.202006484","volume":"17","author":"F Oroojalian","year":"2021","unstructured":"Oroojalian F, Beygi M, Baradaran B, Mokhtarzadeh A, Shahbazi M. Immune cell Membrane-Coated biomimetic nanoparticles for targeted Cancer therapy. Small. 2021;17:2006484.","journal-title":"Small"},{"key":"3572_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.addr.2019.07.006","volume":"144","author":"R Mohammadpour","year":"2019","unstructured":"Mohammadpour R, Dobrovolskaia MA, Cheney DL, Greish KF, Ghandehari H. Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications. Adv Drug Deliv Rev. 2019;144:112\u201332.","journal-title":"Adv Drug Deliv Rev"},{"key":"3572_CR18","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"C-MJ Hu","year":"2011","unstructured":"Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108:10980\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3572_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3572_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/pharmaceutics15020621","volume":"15","author":"J Li","year":"2023","unstructured":"Li J, Wei Y, Zhang C, Bi R, Qiu Y, Li Y, et al. Cell-Membrane-Coated nanoparticles for targeted drug delivery to the brain for the treatment of neurological diseases. Pharmaceutics. 2023;15:621.","journal-title":"Pharmaceutics"},{"key":"3572_CR21","doi-asserted-by":"publisher","first-page":"2400514","DOI":"10.1002\/adhm.202400514","volume":"13","author":"Y Ma","year":"2024","unstructured":"Ma Y, Yi J, Ruan J, Ma J, Yang Q, Zhang K, et al. Engineered cell Membrane-Coated nanoparticles: new strategies in glioma targeted therapy and immune modulation. Adv Healthc Mater. 2024;13:2400514.","journal-title":"Adv Healthc Mater"},{"key":"3572_CR22","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.1021\/acs.nanolett.2c01863","volume":"22","author":"T Yin","year":"2022","unstructured":"Yin T, Fan Q, Hu F, Ma X, Yin Y, Wang B, et al. Engineered Macrophage-Membrane-Coated nanoparticles with enhanced PD-1 expression induce Immunomodulation for a synergistic and targeted antiglioblastoma activity. Nano Lett. 2022;22:6606\u201314.","journal-title":"Nano Lett"},{"key":"3572_CR23","doi-asserted-by":"publisher","first-page":"e1285","DOI":"10.1002\/ctm2.1285","volume":"13","author":"N Krishnan","year":"2023","unstructured":"Krishnan N, Fang RH, Zhang L. Cell membrane-coated nanoparticles for the treatment of cancer. Clin Transl Med. 2023;13:e1285.","journal-title":"Clin Transl Med"},{"key":"3572_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s40820-019-0330-9","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating technology: A promising strategy for biomedical applications. Nano-Micro Lett. 2019;11:100.","journal-title":"Nano-Micro Lett"},{"key":"3572_CR25","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1073\/pnas.1412420111","volume":"111","author":"JA Copp","year":"2014","unstructured":"Copp JA, Fang RH, Luk BT, Hu C-MJ, Gao W, Zhang K, et al. Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci U S A. 2014;111:13481\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3572_CR26","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3390\/pharmaceutics15071953","volume":"15","author":"D Fondaj","year":"2023","unstructured":"Fondaj D, Arduino I, Lopedota AA, Denora N, Iacobazzi RM. Exploring the microfluidic production of biomimetic hybrid nanoparticles and their pharmaceutical applications. Pharmaceutics. 2023;15:1953.","journal-title":"Pharmaceutics"},{"key":"3572_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.nanoms.2021.12.001","volume":"4","author":"K Guo","year":"2022","unstructured":"Guo K, Xiao N, Liu Y, Wang Z, T\u00f3th J, Gyenis J, et al. Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: opportunities and challenges. Nano Mater Sci. 2022;4:295\u2013321.","journal-title":"Nano Mater Sci"},{"key":"3572_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12951-023-02004-z","volume":"21","author":"W Li","year":"2023","unstructured":"Li W, Cheng J, He F, Zhang P, Zhang N, Wang J, et al. Cell membrane-based nanomaterials for theranostics of central nervous system diseases. J Nanobiotechnol. 2023;21:276.","journal-title":"J Nanobiotechnol"},{"key":"3572_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2217\/nnm.12.153","volume":"8","author":"S Aryal","year":"2013","unstructured":"Aryal S, Hu C-MJ, Fang RH, Dehaini D, Carpenter C, Zhang D-E, et al. Erythrocyte Membrane-Cloaked polymeric nanoparticles for controlled drug loading and release. Nanomed. 2013;8:1271\u201380.","journal-title":"Nanomed"},{"key":"3572_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2017.08.027","volume":"264","author":"Z Chai","year":"2017","unstructured":"Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K, et al. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Controlled Release. 2017;264:102\u201311.","journal-title":"J Controlled Release"},{"key":"3572_CR31","doi-asserted-by":"publisher","first-page":"1803717","DOI":"10.1002\/adma.201803717","volume":"30","author":"Y Zou","year":"2018","unstructured":"Zou Y, Liu Y, Yang Z, Zhang D, Lu Y, Zheng M, et al. Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine. Adv Mater. 2018;30:1803717.","journal-title":"Adv Mater"},{"key":"3572_CR32","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","volume":"13","author":"Z Chai","year":"2019","unstructured":"Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, et al. Ligand-Modified cell membrane enables the targeted delivery of drug nanocrystals to glioma. ACS Nano. 2019;13:5591\u2013601.","journal-title":"ACS Nano"},{"key":"3572_CR33","doi-asserted-by":"publisher","first-page":"563938","DOI":"10.3389\/fonc.2020.563938","volume":"10","author":"Y Cui","year":"2020","unstructured":"Cui Y, Sun J, Hao W, Chen M, Wang Y, Xu F, et al. Dual-Target Peptide-Modified erythrocyte Membrane-Enveloped PLGA nanoparticles for the treatment of glioma. Front Oncol. 2020;10:563938.","journal-title":"Front Oncol"},{"key":"3572_CR34","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","volume":"27","author":"Y Han","year":"2020","unstructured":"Han Y, Chu X, Cui L, Fu S, Gao C, Li Y, et al. Neuronal mitochondria-targeted therapy for alzheimer\u2019s disease by systemic delivery of Resveratrol using dual-modified novel biomimetic nanosystems. Drug Deliv. 2020;27:502\u201318.","journal-title":"Drug Deliv"},{"key":"3572_CR35","doi-asserted-by":"publisher","first-page":"2301361","DOI":"10.1002\/advs.202301361","volume":"10","author":"Y Su","year":"2023","unstructured":"Su Y, Huang Y, Kou Q, Lu L, Jiang H, Li X, et al. Study on the role of an erythrocyte Membrane-Coated nanotheranostic system in targeted immune regulation of alzheimer\u2019s disease. Adv Sci. 2023;10:2301361.","journal-title":"Adv Sci"},{"key":"3572_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jconrel.2023.12.030","volume":"366","author":"J Gu","year":"2024","unstructured":"Gu J, Yan C, Yin S, Wu H, Liu C, Xue A, et al. Erythrocyte membrane-coated nanocarriers modified by TGN for alzheimer\u2019s disease. J Controlled Release. 2024;366:448\u201359.","journal-title":"J Controlled Release"},{"key":"3572_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2018.03.028","volume":"543","author":"H Hua","year":"2018","unstructured":"Hua H, Zhang X, Mu H, Meng Q, Jiang Y, Wang Y, et al. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. Int J Pharm. 2018;543:179\u201389.","journal-title":"Int J Pharm"},{"key":"3572_CR38","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1016\/j.biomaterials.2009.02.051","volume":"30","author":"Y Liu","year":"2009","unstructured":"Liu Y, Huang R, Han L, Ke W, Shao K, Ye L, et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials. 2009;30:4195\u2013202.","journal-title":"Biomaterials"},{"key":"3572_CR39","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1182\/blood-2004-08-2980","volume":"105","author":"M Olsson","year":"2005","unstructured":"Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg P-A. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood. 2005;105:3577\u201382.","journal-title":"Blood"},{"key":"3572_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12645-023-00167-w","volume":"14","author":"Q Li","year":"2023","unstructured":"Li Q, Shen J, Wu L, Lei S, Yang Y, Xu W, et al. Functional targeted therapy for glioma based on platelet membrane-coated nanogels. Cancer Nanotechnol. 2023;14:12.","journal-title":"Cancer Nanotechnol"},{"key":"3572_CR41","doi-asserted-by":"publisher","first-page":"122851","DOI":"10.1016\/j.ijpharm.2023.122851","volume":"636","author":"J Ji","year":"2023","unstructured":"Ji J, Lian W, Zhang Y, Lin D, Wang J, Mo Y, et al. Preoperative administration of a biomimetic platelet nanodrug enhances postoperative drug delivery by bypassing thrombus. Int J Pharm. 2023;636:122851.","journal-title":"Int J Pharm"},{"key":"3572_CR42","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","volume":"122","author":"M Koupenova","year":"2018","unstructured":"Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res. 2018;122:337\u201351.","journal-title":"Circ Res"},{"key":"3572_CR43","doi-asserted-by":"publisher","first-page":"2000018","DOI":"10.1002\/sstr.202000018","volume":"1","author":"S Wang","year":"2020","unstructured":"Wang S, Duan Y, Zhang Q, Komarla A, Gong H, Gao W, et al. Drug targeting via platelet Membrane\u2013Coated nanoparticles. Small Struct. 2020;1:2000018.","journal-title":"Small Struct"},{"key":"3572_CR44","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.7150\/thno.27466","volume":"8","author":"M Li","year":"2018","unstructured":"Li M, Liu Y, Chen J, Liu T, Gu Z, Zhang J, et al. Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics. Theranostics. 2018;8:4870\u201383.","journal-title":"Theranostics"},{"key":"3572_CR45","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","volume":"13","author":"J Xu","year":"2019","unstructured":"Xu J, Wang X, Yin H, Cao X, Hu Q, Lv W, et al. Sequentially Site-Specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke. ACS Nano. 2019;13:8577\u201388.","journal-title":"ACS Nano"},{"key":"3572_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.actbio.2021.12.009","volume":"140","author":"W Yu","year":"2022","unstructured":"Yu W, Yin N, Yang Y, Xuan C, Liu X, Liu W, et al. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection. Acta Biomater. 2022;140:625\u201340.","journal-title":"Acta Biomater"},{"key":"3572_CR47","doi-asserted-by":"publisher","first-page":"17560","DOI":"10.1021\/acsanm.3c02620","volume":"6","author":"J-W Cui","year":"2023","unstructured":"Cui J-W, Feng H-C, Xu C, Jiang D-Y, Zhang K-H, Gao N, et al. Platelet Membrane-Encapsulated Ginkgolide B biomimetic nanoparticles for the treatment of ischemic stroke. ACS Appl Nano Mater. 2023;6:17560\u201371.","journal-title":"ACS Appl Nano Mater"},{"key":"3572_CR48","doi-asserted-by":"publisher","first-page":"104783","DOI":"10.1016\/j.jddst.2023.104783","volume":"87","author":"L Lv","year":"2023","unstructured":"Lv L, Liu T, Zhang T, Sun J, Sang J, Wang H, et al. Protective capacity in stroke treatment of AZD6482-loaded platelet membrane-coated \u03b3-Fe2O3. J Drug Deliv Sci Technol. 2023;87:104783.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3572_CR49","doi-asserted-by":"publisher","first-page":"2311128","DOI":"10.1002\/smll.202311128","volume":"20","author":"X Xu","year":"2024","unstructured":"Xu X, Zhang X, Li R, Yang X, Fu P, Feng R, et al. Platelet Membrane-Coated Curcumin\u2010PLGA nanoparticles promote Astrocyte\u2010Neuron transdifferentiation for intracerebral hemorrhage treatment. Small. 2024;20:2311128.","journal-title":"Small"},{"key":"3572_CR50","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1182\/blood-2008-04-144758","volume":"112","author":"G Stoll","year":"2008","unstructured":"Stoll G, Kleinschnitz C, Nieswandt B. Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment. Blood. 2008;112:3555\u201362.","journal-title":"Blood"},{"key":"3572_CR51","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","volume":"14","author":"M Li","year":"2020","unstructured":"Li M, Li J, Chen J, Liu Y, Cheng X, Yang F, et al. Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke. ACS Nano. 2020;14:2024\u201335.","journal-title":"ACS Nano"},{"key":"3572_CR52","first-page":"3805","volume":"63","author":"VV Glinsky","year":"2003","unstructured":"Glinsky VV, Glinsky GV, Glinskii OV, Huxley VH, Turk JR, Mossine VV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 2003;63:3805\u201311.","journal-title":"Cancer Res"},{"key":"3572_CR53","doi-asserted-by":"publisher","first-page":"1900612","DOI":"10.1002\/adhm.201900612","volume":"8","author":"C Tapeinos","year":"2019","unstructured":"Tapeinos C, Tomatis F, Battaglini M, Larra\u00f1aga A, Marino A, Telleria IA, et al. Cell Membrane-Coated magnetic nanocubes with a homotypic targeting ability increase intracellular temperature due to ROS scavenging and act as a versatile theranostic system for glioblastoma multiforme. Adv Healthc Mater. 2019;8:1900612.","journal-title":"Adv Healthc Mater"},{"key":"3572_CR54","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.3390\/molecules26165103","volume":"26","author":"Y Fan","year":"2021","unstructured":"Fan Y, Hao W, Cui Y, Chen M, Chu X, Yang Y, et al. Cancer cell Membrane-Coated nanosuspensions for enhanced chemotherapeutic treatment of glioma. Molecules. 2021;26:5103.","journal-title":"Molecules"},{"key":"3572_CR55","first-page":"4402","volume":"6","author":"Y Fan","year":"2021","unstructured":"Fan Y, Cui Y, Hao W, Chen M, Liu Q, Wang Y, et al. Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma. Bioact Mater. 2021;6:4402\u201314.","journal-title":"Bioact Mater"},{"key":"3572_CR56","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1038\/s41467-022-31799-y","volume":"13","author":"G Lu","year":"2022","unstructured":"Lu G, Wang X, Li F, Wang S, Zhao J, Wang J, et al. Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma. Nat Commun. 2022;13:4214.","journal-title":"Nat Commun"},{"key":"3572_CR57","doi-asserted-by":"publisher","first-page":"2203958","DOI":"10.1002\/adma.202203958","volume":"34","author":"Y Zou","year":"2022","unstructured":"Zou Y, Wang Y, Xu S, Liu Y, Yin J, Lovejoy DB, et al. Brain Co-Delivery of Temozolomide and cisplatin for combinatorial glioblastoma chemotherapy. Adv Mater. 2022;34:2203958.","journal-title":"Adv Mater"},{"key":"3572_CR58","doi-asserted-by":"publisher","first-page":"2209239","DOI":"10.1002\/adfm.202209239","volume":"32","author":"D Zhang","year":"2022","unstructured":"Zhang D, Sun Y, Wang S, Zou Y, Zheng M, Shi B. Brain-Targeting metastatic tumor cell membrane cloaked biomimetic nanomedicines mediate potent chemodynamic and RNAi combinational therapy of glioblastoma. Adv Funct Mater. 2022;32:2209239.","journal-title":"Adv Funct Mater"},{"key":"3572_CR59","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12951-023-01960-w","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Tang X, Zhao M, Zhang Y, Xiao Y, Liu Y, et al. Biomimetic hypoxia-triggered RNAi nanomedicine for synergistically mediating chemo\/radiotherapy of glioblastoma. J Nanobiotechnol. 2023;21:210.","journal-title":"J Nanobiotechnol"},{"key":"3572_CR60","doi-asserted-by":"publisher","first-page":"1909369","DOI":"10.1002\/adfm.201909369","volume":"30","author":"C Wang","year":"2020","unstructured":"Wang C, Wu B, Wu Y, Song X, Zhang S, Liu Z. Camouflaging nanoparticles with brain metastatic tumor cell membranes: A new strategy to traverse Blood\u2013Brain barrier for imaging and therapy of brain tumors. Adv Funct Mater. 2020;30:1909369.","journal-title":"Adv Funct Mater"},{"key":"3572_CR61","doi-asserted-by":"publisher","first-page":"2200521","DOI":"10.1002\/adhm.202200521","volume":"11","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang M, Chi S, Zhu M, Wang C, Liu Z. Brain tumor cell Membrane-Coated Lanthanide\u2010Doped nanoparticles for NIR\u2010IIb luminescence imaging and surgical navigation of glioma. Adv Healthc Mater. 2022;11:2200521.","journal-title":"Adv Healthc Mater"},{"key":"3572_CR62","doi-asserted-by":"publisher","first-page":"5930","DOI":"10.1021\/jacs.2c13701","volume":"145","author":"H Zhang","year":"2023","unstructured":"Zhang H, Guan S, Wei T, Wang T, Zhang J, You Y, et al. Homotypic Membrane-Enhanced Blood\u2013Brain barrier crossing and glioblastoma targeting for precise surgical resection and photothermal therapy. J Am Chem Soc. 2023;145:5930\u201340.","journal-title":"J Am Chem Soc"},{"key":"3572_CR63","doi-asserted-by":"publisher","first-page":"160181","DOI":"10.1016\/j.cej.2025.160181","volume":"507","author":"J Lin","year":"2025","unstructured":"Lin J, Sun Z, Huang Y, Liu Q, Shen M, Shao C, et al. Glioma stem cell membrane-camouflaged photothermal nanozyme for synergistic antitumor via dual-targeted drug delivery across blood-brain barrier. Chem Eng J. 2025;507:160181.","journal-title":"Chem Eng J"},{"key":"3572_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1186\/s12951-024-02870-1","volume":"22","author":"P Liu","year":"2024","unstructured":"Liu P, Lan S, Gao D, Hu D, Chen Z, Li Z, et al. Targeted blood-brain barrier penetration and precise imaging of infiltrative glioblastoma margins using hybrid cell membrane-coated ICG liposomes. J Nanobiotechnol. 2024;22:603.","journal-title":"J Nanobiotechnol"},{"key":"3572_CR65","doi-asserted-by":"crossref","unstructured":"Kroll AV, Fang RH, Jiang Y, Zhou J, Wei X, Yu CL, et al. Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity. Adv Mater Deerfield Beach Fla. 2017;29(47):1703969.","DOI":"10.1002\/adma.201703969"},{"key":"3572_CR66","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41375-021-01432-w","volume":"36","author":"DT Johnson","year":"2022","unstructured":"Johnson DT, Zhou J, Kroll AV, Fang RH, Yan M, Xiao C, et al. Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy. Leukemia. 2022;36:994\u20131005.","journal-title":"Leukemia"},{"key":"3572_CR67","doi-asserted-by":"crossref","unstructured":"Chen H, Zhang S, Fang Q, He H, Ren J, Sun D, et al. Biomimetic nanosonosensitizers combined with noninvasive ultrasound actuation to reverse drug resistance and Sonodynamic-Enhanced chemotherapy against orthotopic glioblastoma. ACS Nano. 2023;17(1):421\u201336.","DOI":"10.1021\/acsnano.2c08861"},{"key":"3572_CR68","doi-asserted-by":"publisher","first-page":"2004346","DOI":"10.1002\/adfm.202004346","volume":"30","author":"Y Duan","year":"2020","unstructured":"Duan Y, Wu M, Hu D, Pan Y, Hu F, Liu X, et al. Biomimetic nanocomposites cloaked with bioorthogonally labeled glioblastoma cell membrane for targeted multimodal imaging of brain tumors. Adv Funct Mater. 2020;30:2004346.","journal-title":"Adv Funct Mater"},{"key":"3572_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.matt.2023.01.012","volume":"6","author":"M Shao","year":"2023","unstructured":"Shao M, Lopes D, Lopes J, Yousefiasl S, Mac\u00e1rio-Soares A, Peixoto D, et al. Exosome membrane-coated nanosystems: exploring biomedical applications in cancer diagnosis and therapy. Matter. 2023;6:761\u201399.","journal-title":"Matter"},{"key":"3572_CR70","doi-asserted-by":"crossref","unstructured":"Hill ML, Chung S-J, Woo H-J, Park CR, Hadrick K, Nafiujjaman M et al. Exosome-Coated Prussian Blue Nanoparticles for Specific Targeting and Treatment of Glioblastoma. ACS Appl Mater Interfaces. 2024;acsami.4c02364.","DOI":"10.1021\/acsami.4c02364"},{"key":"3572_CR71","first-page":"101006","volume":"20","author":"Y Lee","year":"2025","unstructured":"Lee Y, Kang S, Thuy LT, Son M, Park JY, Ahn SB, et al. Exosome-membrane and polymer-based hybrid-complex for systemic delivery of plasmid DNA into brains for the treatment of glioblastoma. Asian J Pharm Sci. 2025;20:101006.","journal-title":"Asian J Pharm Sci"},{"key":"3572_CR72","doi-asserted-by":"publisher","first-page":"e2200289","DOI":"10.1002\/smtd.202200289","volume":"6","author":"J Lopes","year":"2022","unstructured":"Lopes J, Lopes D, Pereira-Silva M, Peixoto D, Veiga F, Hamblin MR, et al. Macrophage cell Membrane-Cloaked nanoplatforms for biomedical applications. Small Methods. 2022;6:e2200289.","journal-title":"Small Methods"},{"key":"3572_CR73","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00401-015-1417-0","volume":"129","author":"A Haarmann","year":"2015","unstructured":"Haarmann A, Nowak E, Dei\u00df A, van der Pol S, Monoranu C-M, Kooij G, et al. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin \u03b1-4-transduced outside-in signalling. Acta Neuropathol (Berl). 2015;129:639\u201352.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3572_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biomaterials.2019.04.026","volume":"211","author":"J Lai","year":"2019","unstructured":"Lai J, Deng G, Sun Z, Peng X, Li J, Gong P, et al. Scaffolds biomimicking macrophages for a glioblastoma NIR-Ib imaging guided photothermal therapeutic strategy by crossing Blood-Brain barrier. Biomaterials. 2019;211:48\u201356.","journal-title":"Biomaterials"},{"key":"3572_CR75","doi-asserted-by":"publisher","first-page":"20377","DOI":"10.1021\/acsnano.1c08689","volume":"15","author":"T Xiao","year":"2021","unstructured":"Xiao T, He M, Xu F, Fan Y, Jia B, Shen M, et al. Macrophage Membrane-Camouflaged responsive polymer nanogels enable magnetic resonance Imaging-Guided chemotherapy\/chemodynamic therapy of orthotopic glioma. ACS Nano. 2021;15:20377\u201390.","journal-title":"ACS Nano"},{"key":"3572_CR76","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.jconrel.2024.12.059","volume":"378","author":"S Li","year":"2025","unstructured":"Li S, Zhang J, Yu T, Song G, Ke J, Wang K, et al. Microglia membrane-mediated trans-blood-brain barrier prodrug micelles enhance phagocytosis for glioblastoma chemo-immunotherapy. J Controlled Release. 2025;378:932\u201348.","journal-title":"J Controlled Release"},{"key":"3572_CR77","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.actbio.2025.01.016","volume":"193","author":"W Cheng","year":"2025","unstructured":"Cheng W, Duan Z, Chen H, Wang Y, Wang C, Pan Y, et al. Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma. Acta Biomater. 2025;193:392\u2013405.","journal-title":"Acta Biomater"},{"key":"3572_CR78","doi-asserted-by":"publisher","first-page":"23746","DOI":"10.1021\/acsnano.3c07555","volume":"17","author":"Z Cao","year":"2023","unstructured":"Cao Z, Liu X, Zhang W, Zhang K, Pan L, Zhu M, et al. Biomimetic macrophage Membrane-Camouflaged nanoparticles induce ferroptosis by promoting mitochondrial damage in glioblastoma. ACS Nano. 2023;17:23746\u201360.","journal-title":"ACS Nano"},{"key":"3572_CR79","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1039\/D4BM00357H","volume":"12","author":"B Zhang","year":"2024","unstructured":"Zhang B, Yang R, Yu H, Peng Y, Huang H, Hameed MMA, et al. Macrophage membrane-camouflaged nanoclusters of ultrasmall iron oxide nanoparticles for precision glioma theranostics. Biomater Sci. 2024;12:2705\u201316.","journal-title":"Biomater Sci"},{"key":"3572_CR80","first-page":"529","volume":"6","author":"Y Han","year":"2021","unstructured":"Han Y, Gao C, Wang H, Sun J, Liang M, Feng Y, et al. Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in alzheimer\u2019s disease mice. Bioact Mater. 2021;6:529\u201342.","journal-title":"Bioact Mater"},{"key":"3572_CR81","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.7150\/thno.99260","volume":"14","author":"C Geng","year":"2024","unstructured":"Geng C, Ren X, Cao P, Chu X, Wei P, Liu Q, et al. Macrophage membrane\u2013biomimetic nanoparticles target inflammatory microenvironment for epilepsy treatment. Theranostics. 2024;14:6652\u201370.","journal-title":"Theranostics"},{"key":"3572_CR82","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","volume":"35","author":"GC Jickling","year":"2015","unstructured":"Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, Sharp FR. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2015;35:888\u2013901.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"3572_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-014-1381-0","volume":"129","author":"I Perez-de-Puig","year":"2015","unstructured":"Perez-de-Puig I, Mir\u00f3-Mur F, Ferrer-Ferrer M, Gelpi E, Pedragosa J, Justicia C, et al. Neutrophil recruitment to the brain in mouse and human ischemic stroke. Acta Neuropathol (Berl). 2015;129:239\u201357.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3572_CR84","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","volume":"15","author":"L Feng","year":"2021","unstructured":"Feng L, Dou C, Xia Y, Li B, Zhao M, Yu P, et al. Neutrophil-like Cell-Membrane-Coated nanozyme therapy for ischemic brain damage and Long-Term neurological functional recovery. ACS Nano. 2021;15:2263\u201380.","journal-title":"ACS Nano"},{"key":"3572_CR85","doi-asserted-by":"publisher","first-page":"27743","DOI":"10.1021\/acsami.2c09020","volume":"14","author":"S Liu","year":"2022","unstructured":"Liu S, Xu J, Liu Y, You Y, Xie L, Tong S, et al. Neutrophil-Biomimetic nanobuffer for remodeling the microenvironment in the infarct core and protecting neurons in the penumbra via neutralization of detrimental factors to treat ischemic stroke. ACS Appl Mater Interfaces. 2022;14:27743\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3572_CR86","doi-asserted-by":"publisher","first-page":"113841","DOI":"10.1016\/j.biopha.2022.113841","volume":"156","author":"H Hosseinalizadeh","year":"2022","unstructured":"Hosseinalizadeh H, Mahmoodpour M, Razaghi Bahabadi Z, Hamblin MR, Mirzaei H. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review. Biomed Pharmacother Biomedecine Pharmacother. 2022;156:113841.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"3572_CR87","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jconrel.2023.08.020","volume":"362","author":"H Chen","year":"2023","unstructured":"Chen H, Ji J, Zhang L, Chen T, Zhang Y, Zhang F, et al. Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy. J Controlled Release. 2023;362:479\u201388.","journal-title":"J Controlled Release"},{"key":"3572_CR88","doi-asserted-by":"publisher","first-page":"35559","DOI":"10.1021\/acsnano.4c13470","volume":"18","author":"W He","year":"2024","unstructured":"He W, Lv W, Liu L, Gong Y, Song K, Xu J, et al. Enhanced antiglioma effect by a vitamin D3-Inserted lipid hybrid neutrophil membrane biomimetic multimodal nanoplatform. ACS Nano. 2024;18:35559\u201374.","journal-title":"ACS Nano"},{"key":"3572_CR89","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","volume":"19","author":"N Shimasaki","year":"2020","unstructured":"Shimasaki N, Jain A, Campana D. NK cells for cancer immunotherapy. Nat Rev Drug Discov. 2020;19:200\u201318.","journal-title":"Nat Rev Drug Discov"},{"key":"3572_CR90","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1021\/acsnano.0c03824","volume":"14","author":"G Deng","year":"2020","unstructured":"Deng G, Peng X, Sun Z, Zheng W, Yu J, Du L, et al. Natural-Killer-Cell-Inspired nanorobots with Aggregation-Induced emission characteristics for Near-Infrared-II Fluorescence-Guided glioma theranostics. ACS Nano. 2020;14:11452\u201362.","journal-title":"ACS Nano"},{"key":"3572_CR91","doi-asserted-by":"publisher","first-page":"2301439","DOI":"10.1002\/smll.202301439","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zhang Y, Wang X, Zhou Y, Qi J, Gu L, et al. A Trojan-Horse\u2010Like biomimetic Nano\u2010NK to elicit an immunostimulatory tumor microenvironment for enhanced GBM Chemo\u2010Immunotherapy. Small. 2023;19:2301439.","journal-title":"Small"},{"key":"3572_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","volume":"112","author":"H-Y Chen","year":"2020","unstructured":"Chen H-Y, Deng J, Wang Y, Wu C-Q, Li X, Dai H-W. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020;112:1\u201313.","journal-title":"Acta Biomater"},{"key":"3572_CR93","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.2147\/IJN.S333279","volume":"16","author":"L Wu","year":"2021","unstructured":"Wu L, Li Q, Deng J, Shen J, Xu W, Yang W, et al. Platelet-Tumor cell hybrid Membrane-Camouflaged nanoparticles for enhancing therapy efficacy in glioma. Int J Nanomed. 2021;16:8433\u201346.","journal-title":"Int J Nanomed"},{"key":"3572_CR94","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.12.066","volume":"378","author":"M Zhao","year":"2025","unstructured":"Zhao M, Lin Y, Zeng Y, Lv Z, Liang J, Tang P, et al. Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases. J Controlled Release. 2025;378:763\u201375.","journal-title":"J Controlled Release"},{"key":"3572_CR95","doi-asserted-by":"publisher","first-page":"2311760","DOI":"10.1002\/adma.202311760","volume":"36","author":"M Song","year":"2024","unstructured":"Song M, Tian J, Wang L, Dong S, Fu K, Chen S, et al. Efficient delivery of lomitapide using hybrid Membrane-Coated tetrahedral DNA nanostructures for glioblastoma therapy. Adv Mater. 2024;36:2311760.","journal-title":"Adv Mater"},{"key":"3572_CR96","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.apsb.2021.09.025","volume":"12","author":"Y Shi","year":"2022","unstructured":"Shi Y, Qian H, Rao P, Mu D, Liu Y, Liu G, et al. Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases. Acta Pharm Sin B. 2022;12:1126\u201347.","journal-title":"Acta Pharm Sin B"},{"key":"3572_CR97","doi-asserted-by":"publisher","first-page":"1706759","DOI":"10.1002\/adma.201706759","volume":"30","author":"RH Fang","year":"2018","unstructured":"Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30:1706759.","journal-title":"Adv Mater"},{"key":"3572_CR98","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.molmed.2023.12.004","volume":"30","author":"B Ach\u00f3n Buil","year":"2024","unstructured":"Ach\u00f3n Buil B, Rentsch NH, Weber RZ, Rickenbach C, Halliday SJ, Hotta A, et al. Beneath the radar: immune-evasive cell sources for stroke therapy. Trends Mol Med. 2024;30:223\u201338.","journal-title":"Trends Mol Med"},{"key":"3572_CR99","doi-asserted-by":"publisher","first-page":"122065","DOI":"10.1016\/j.biomaterials.2023.122065","volume":"296","author":"N Krishnan","year":"2023","unstructured":"Krishnan N, Peng F-X, Mohapatra A, Fang RH, Zhang L. Genetically engineered cellular nanoparticles for biomedical applications. Biomaterials. 2023;296:122065.","journal-title":"Biomaterials"},{"key":"3572_CR100","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cytogfr.2022.05.003","volume":"66","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Fu M, Zhu D, Wang X, Li N, Ren L, et al. Genetically modified Immunomodulatory cell-based biomaterials in tissue regeneration and engineering. Cytokine Growth Factor Rev. 2022;66:53\u201373.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3572_CR101","doi-asserted-by":"publisher","first-page":"17080","DOI":"10.1021\/acsnano.1c03800","volume":"15","author":"V Chugh","year":"2021","unstructured":"Chugh V, Vijaya Krishna K, Pandit A. Cell Membrane-Coated mimics: A methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation. ACS Nano. 2021;15:17080\u2013123.","journal-title":"ACS Nano"},{"key":"3572_CR102","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1039\/D4NR00415A","volume":"16","author":"Kenry","year":"2024","unstructured":"Kenry. Microfluidic-assisted formulation of cell membrane-camouflaged anisotropic nanostructures. Nanoscale. 2024;16:7874\u201383.","journal-title":"Nanoscale"},{"key":"3572_CR103","doi-asserted-by":"publisher","first-page":"2400012","DOI":"10.1002\/anbr.202400012","volume":"4","author":"N Desai","year":"2024","unstructured":"Desai N, Tambe V, Pofali P, Vora LK. Cell Membrane-Coated nanoparticles: A new frontier in Immunomodulation. Adv NanoBiomed Res. 2024;4:2400012.","journal-title":"Adv NanoBiomed Res"},{"key":"3572_CR104","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.1038\/s41467-022-33889-3","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Pan D, Chen S, Martikainen M-V, K\u00e5rlund A, Ke J, et al. Systematic design of cell membrane coating to improve tumor targeting of nanoparticles. Nat Commun. 2022;13:6181.","journal-title":"Nat Commun"},{"key":"3572_CR105","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1038\/s41467-023-40814-9","volume":"14","author":"L Li","year":"2023","unstructured":"Li L, Zhang M, Li J, Liu T, Bao Q, Li X, et al. Cholesterol removal improves performance of a model biomimetic system to co-deliver a photothermal agent and a STING agonist for cancer immunotherapy. Nat Commun. 2023;14:5111.","journal-title":"Nat Commun"},{"key":"3572_CR106","doi-asserted-by":"publisher","first-page":"e2214757120","DOI":"10.1073\/pnas.2214757120","volume":"120","author":"D Zou","year":"2023","unstructured":"Zou D, Wu Z, Yi X, Hui Y, Yang G, Liu Y, et al. Nanoparticle elasticity regulates the formation of cell membrane-coated nanoparticles and their nano-bio interactions. Proc Natl Acad Sci. 2023;120:e2214757120.","journal-title":"Proc Natl Acad Sci"},{"key":"3572_CR107","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin E, Levental I, Mayor S, Eggeling C. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3572_CR108","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41580-022-00524-4","volume":"24","author":"I Levental","year":"2023","unstructured":"Levental I, Lyman E. Regulation of membrane protein structure and function by their lipid nano-environment. Nat Rev Mol Cell Biol. 2023;24:107\u201322.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3572_CR109","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41565-023-01533-w","volume":"19","author":"N Krishnan","year":"2024","unstructured":"Krishnan N, Jiang Y, Zhou J, Mohapatra A, Peng F-X, Duan Y, et al. A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering. Nat Nanotechnol. 2024;19:345\u201353.","journal-title":"Nat Nanotechnol"},{"key":"3572_CR110","doi-asserted-by":"publisher","first-page":"101716","DOI":"10.1016\/j.mtbio.2025.101716","volume":"32","author":"P Grav\u00e1n","year":"2025","unstructured":"Grav\u00e1n P, Marchal JA, Galisteo-Gonz\u00e1lez F. Improving tumor treatment: cell membrane-coated nanoparticles for targeted therapies. Mater Today Bio. 2025;32:101716.","journal-title":"Mater Today Bio"},{"key":"3572_CR111","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1016\/j.cell.2024.09.022","volume":"187","author":"S Gao","year":"2024","unstructured":"Gao S, Fang A, Huang Y, Giunchiglia V, Noori A, Schwarz JR, et al. Empowering biomedical discovery with AI agents. Cell. 2024;187:6125\u201351.","journal-title":"Cell"},{"key":"3572_CR112","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12915-024-01883-4","volume":"22","author":"Z-F Gu","year":"2024","unstructured":"Gu Z-F, Hao Y-D, Wang T-Y, Cai P-L, Zhang Y, Deng K-J, et al. Prediction of blood\u2013brain barrier penetrating peptides based on data augmentation with augur. BMC Biol. 2024;22:86.","journal-title":"BMC Biol"},{"key":"3572_CR113","doi-asserted-by":"crossref","unstructured":"Ji Z, Guo W, Wood EL, Liu J, Sakkiah S, Xu X, et al. Machine learning models for predicting cytotoxicity of nanomaterials. Chem Res Toxicol. 2022;35(2):125\u201339.","DOI":"10.1021\/acs.chemrestox.1c00310"},{"key":"3572_CR114","doi-asserted-by":"crossref","unstructured":"Puzyn T. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat Nanotechnol. 2011;6(3):175\u20138.","DOI":"10.1038\/nnano.2011.10"},{"key":"3572_CR115","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/17435390.2014.930195","volume":"9","author":"A Gajewicz","year":"2015","unstructured":"Gajewicz A, Schaeublin N, Rasulev B, Hussain S, Leszczynska D, Puzyn T, et al. Towards Understanding mechanisms governing cytotoxicity of metal oxides nanoparticles: hints from nano-QSAR studies. Nanotoxicology. 2015;9:313\u201325.","journal-title":"Nanotoxicology"},{"key":"3572_CR116","doi-asserted-by":"crossref","unstructured":"Mikolajczyk A, Gajewicz A, Mulkiewicz E, Rasulev B, Marchelek M, Diak M, et al. Nano-QSAR modeling for ecosafe design of heterogeneous TiO2-based nano-photocatalysts. Environ Sci: Nano. 2018;5(5):1150\u201360.","DOI":"10.1039\/C8EN00085A"},{"key":"3572_CR117","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","volume":"18","author":"M Zhu","year":"2023","unstructured":"Zhu M, Zhuang J, Li Z, Liu Q, Zhao R, Gao Z, et al. Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures. Nat Nanotechnol. 2023;18:657\u201366.","journal-title":"Nat Nanotechnol"},{"key":"3572_CR118","doi-asserted-by":"crossref","unstructured":"Luo J, Molbay M, Chen Y, Horvath I, Kadletz K, Kick B, et al. Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning. Nat Biotechnol. 2025;1\u201314.","DOI":"10.1038\/s41587-024-02528-1"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03572-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:02:50Z","timestamp":1751932970000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03572-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3572"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03572-y","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have read and approved the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"493"}}